The FDA recommends healthcare professionals co-prescribe the opioid overdose reversal drug with all opioid prescriptions.

A study of 41,000 adults finds that only treatment with buprenorphine or methadone reduced risk of overdose.

The guideline covers a wide range of relevant topics, including pain, dosing, dangerous co-prescribing, comorbidities, and more.

Four research sites will test proven opioid prevention and treatment interventions, hoping to reduce overdose deaths by 40% over three years.

The reSET-O app uses cognitive behavioral therapy techniques to assist patients engaged in medication-assisted therapy for opioid dependence.